Transcriptional signatures of human peripheral blood mononuclear cells can identify the risk of tuberculosis progression from latent infection among individuals with silicosis

Emerg Microbes Infect. 2021 Dec;10(1):1536-1544. doi: 10.1080/22221751.2021.1915184.

Abstract

www.clinicaltrials.gov (NCT02430259).

Keywords: RNA sequencing; Tuberculosis; biomarker; interferon-gamma; latent tuberculosis infection; peripheral blood mononuclear cell.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Disease Progression
  • Female
  • Humans
  • Latent Infection
  • Leukocytes, Mononuclear / chemistry*
  • Leukocytes, Mononuclear / immunology
  • Male
  • Middle Aged
  • Risk Factors
  • Silicosis / complications*
  • Silicosis / genetics*
  • Silicosis / immunology
  • Tuberculosis / epidemiology
  • Tuberculosis / etiology
  • Tuberculosis / genetics*
  • Tuberculosis / pathology
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT02430259

Grants and funding

This work was supported by the Key Technologies Research and Development Program for Infectious Diseases of China[grant number 2017ZX10201302-004]; National Natural Science Foundation of China (NSFC) under grant number [81801975]; Shanghai Sailing Program under grant number [18YF1402800] and Key Laboratory Project of Shanghai Science and Technology Commission [grant numbers 20dz2210400]..